← Back to Search

Behavioural Intervention

Mobile Health Intervention for HIV/AIDS

N/A
Waitlist Available
Led By Judy Y Tan, Ph.D.
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new mobile health intervention called LetSync to see if it is acceptable and feasible, and if it improves retention in care and antiretroviral adherence.

Who is the study for?
This trial is for cisgender men over 18 in a committed relationship, who are racial/ethnic minorities living with HIV or have a partner who is. They must own and use a smartphone and be willing to consent to the study. It's not for those fearing intimate partner violence from participating or unable to disclose their HIV status.
What is being tested?
The LetSync mHealth intervention is being tested on couples where at least one partner has HIV. The study will see if using the app helps them stay on track with their treatment and care. Participants will first try version 1.0, then some will test an updated version after feedback.
What are the potential side effects?
Since this trial involves an mHealth app rather than medication, traditional side effects aren't expected; however, participants may experience privacy concerns or stress related to adherence monitoring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Levels of Antiretroviral (ARV) concentration in dried blood spot (DBS) samples
Presence of Antiretroviral (ARV) medication in urine sample
Self-reported measure I of antiretroviral therapy (ART) adherence
+2 more
Secondary study objectives
Acceptability of or Satisfaction in using LetSync app v1.0
Feasibility or usability of LetSync app v1.0 (how easy or convenient is v1.0 to use)
Self-reported care engagement

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
This arm will start the intervention using LetSync app v1.0 from T1 to T4, baseline/Month 0 to Month 14.
Group II: Waitlist-Control GroupActive Control1 Intervention
This arm will wait to begin the intervention using the LetSync app v2.0 from T3 to T4, Month 8 to Month 14.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,591 Previous Clinical Trials
14,901,443 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,928 Previous Clinical Trials
2,744,859 Total Patients Enrolled
Judy Y Tan, Ph.D.Principal InvestigatorUniversity of California, San Francisco

Media Library

LetSync v1.0 (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04951544 — N/A
HIV/AIDS Research Study Groups: Waitlist-Control Group, Intervention Group
HIV/AIDS Clinical Trial 2023: LetSync v1.0 Highlights & Side Effects. Trial Name: NCT04951544 — N/A
LetSync v1.0 (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04951544 — N/A
~7 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top